Lv5
840 积分 2024-12-09 加入
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
3小时前
待确认
The tissue-specific regulation of immunobiology by IL-17 signaling
12天前
已完结
In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid
15天前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
22天前
已完结
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
22天前
已完结
IL-17A and IL-17F in tissue homeostasis, inflammation and regeneration
22天前
已完结
Bimekizumab versus Secukinumab in Plaque Psoriasis
22天前
已完结
Vitiligo
28天前
已完结
Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity
28天前
已完结
CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
28天前
已完结
皖公网安备34019202002308
